WithdrawnPhase 3NCT02282176
TINN2: Treat Infection in NeoNates 2
Studying Bronchopulmonary dysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Principal Investigator
- Sailesh KotechaCardiff University
- Intervention
- Azithromycin(drug)
- Eligibility
- All sexes
- Timeline
- 2015 – 2018
Study locations (16)
- Centre Hospitalier Chrétien (CHC), Liège, Belgium
- Assistance Publique Hôpitaux de Paris (APHP), Paris, France
- Inserm-Transfert (IT), Paris, France
- Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France
- Only for children pharmaceuticals (04CP), Paris, France
- Heinrich-Heine-Universität Düsseldorf (UDUS), Düsseldorf, Germany
- University of Ulm (UUlm), Ulm, Germany
- Semmelweis University Budapest, Faculty of Medicine (SOTE), Budapest, Hungary
- Pandy Kalman County Hospital, Gyula, Hungary
- Mario Negri Institute (IRFMN), Milan, Italy
- Advanced Biological Laboratories ABL (ABL SA), Luxembourg, Luxembourg
- Erasmus-University Medical Center (ERAMUS), Rotterdam, Netherlands
- Karolinska Institutet (KI), Stockholm, Sweden
- Cardiff University (CU), Cardiff, United Kingdom
- University of Liverpool (UOL), Liverpool, United Kingdom
- +1 more locations on ClinicalTrials.gov
Collaborators
University of Liverpool · Cardiff University · University of Nottingham · Erasmus Medical Center · Heinrich-Heine-Universität Düsseldorf (UDUS) · Assistance Publique - Hôpitaux de Paris · Mario Negri Institute (IRFMN) · Advanced Biological Laboratories ABL (ABL SA) · Simcyp Limited (SimCyp) · Only For Children Pharmaceuticals · University of Ulm · Karolinska Institutet · Centre Hospitalier Chrétien (CHC) · Semmelweis University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02282176 on ClinicalTrials.govOther trials for Bronchopulmonary dysplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06373289Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm InfantsUniversity of Alabama at Birmingham
- RECRUITINGNCT07109791National Surveillance and Prevention of Neonatal VAPUniversity of Alberta
- RECRUITINGPHASE2NCT07561125Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and BelowInternational Peace Maternity and Child Health Hospital
- RECRUITINGPHASE2NCT06915441Lipid Infusions to Optimize Nutrition TrialThe University of Texas Health Science Center, Houston
- RECRUITINGPHASE1, PHASE2NCT07101640PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaDuke University
- RECRUITINGNCT07273643Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and MortalityUniversity Hospital, Montpellier
- RECRUITINGEARLY PHASE1NCT07120971Metformin for Premature Infants With Bronchopulmonary DysplasiaMedical College of Wisconsin
- RECRUITINGNCT07134387Long-Term Burden of BPD and Health-Related Quality of Life (BronQ Family)Global Foundation for the Care of Newborn Infants